Invention Grant
US08324384B2 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
有权
胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
- Patent Title: Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
- Patent Title (中): 胰高血糖素受体拮抗剂化合物，含有这些化合物的组合物和使用方法
-
Application No.: US13148809Application Date: 2010-02-03
-
Publication No.: US08324384B2Publication Date: 2012-12-04
- Inventor: Songnian Lin , Xibin Liao , Edward Metzger , Emma R. Parmee , Sheryl D. Debenham
- Applicant: Songnian Lin , Xibin Liao , Edward Metzger , Emma R. Parmee , Sheryl D. Debenham
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Anna L. Cucuzzo; John C. Todaro
- International Application: PCT/US2010/022966 WO 20100203
- International Announcement: WO2010/093535 WO 20100819
- Main IPC: C07D209/08
- IPC: C07D209/08 ; C07D209/44 ; C07D215/08 ; C07D217/06 ; C07D401/10 ; C07D403/10 ; C07D403/12
Abstract:
Glucagon receptor antagonist compounds are disclosed. The compounds are useful for treating type 2 diabetes and related conditions. Pharmaceutical compositions and methods of treatment are also included.
Public/Granted literature
- US20110306624A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Public/Granted day:2011-12-15
Information query
